openPR Logo
Press release

Nucleic Acid Therapeutics Market is to Hit USD 12.09 billion in 2030 at a growth rate of 12.71% as per Maximize Market Research study

Nucleic Acid Therapeutics Market

Nucleic Acid Therapeutics Market

Maximize Market Research, a Healthcare business research firm has published a report on the "Nucleic Acid Therapeutics Market". The total market opportunity for Nucleic Acid Therapeutics was USD 5.23 Bn in 2023 and is expected to grow at 12.71 percent CAGR through the forecast period by reaching nearly USD 12.09 Bn.

Request For Free Sample Report : https://www.maximizemarketresearch.com/request-sample/259289/

Nucleic Acid Therapeutics Market Report Scope and Research Methodology

Market Size in 2023: USD 5.23 Billion
Market Size in 2030: USD 12.09 Billion
CAGR: 12.71 Percent
Forecast Period: 2024-2030
Base Year: 2023
Number of Pages: 258
No. of Tables: 49
No. of Charts and Figures: 47
Segment Covered: By Type, Application, End-User and Region
Regional Scope: North America, Europe, Asia Pacific, Middle East and Africa, South America

Report Coverage: Market Share, Size and Forecast by Revenue | 2023-2030, Market Dynamics, Growth Drivers, Restraints, Investment Opportunities, and Key Trends, Competitive Landscape, Key Players Benchmarking, Competitive Analysis, SMR Competition Matrix, Competitive Leadership Mapping, Global Key Players' Market Ranking Analysis.

The Interested Stakeholders can Enquire for the Purchase of the Report : https://www.maximizemarketresearch.com/inquiry-before-buying/259289/

Nucleic Acid Therapeutics Market Overview

The nucleic acid therapeutics market is experiencing significant growth driven by the increasing prevalence of genetic disorders and chronic diseases. The market is segmented based on type, applications, and end-user. The Antisense oligonucleotides (ASOs) Segment held the largest share in 2023. Regionally, North America leads the nucleic acid therapeutics market, due to its strong focus on research and development and the presence of major pharmaceutical companies. The competitive landscape features key players such as Novartis Pharma AG, Agilent Technologies, and Nippon Shinyaku, all investing heavily in advancing nucleic acid-based therapies and expanding their global reach.

Nucleic Acid Therapeutics Market Dynamics

The Nucleic Acid Therapeutics market is driven by the rising prevalence of genetic disorders and chronic diseases such as cancer and neurodegenerative conditions. These therapies offer new solutions for diseases caused by genetic mutations, which traditional treatments often cannot address effectively. For example, Spinraza, an antisense oligonucleotide (ASO) therapy, has made significant strides in treating spinal muscular atrophy (SMA) by targeting faulty genes. As chronic and genetic diseases continue to rise, the demand for NATs is expected to grow. Future opportunities in the NAT market include advancements in targeting mRNA to prevent disease progression and expanding applications beyond rare diseases to more common conditions. However, challenges include the susceptibility of nucleic acids to degradation by cellular enzymes and difficulties in delivering these therapies to the right cells. Advanced technologies are needed to overcome these issues and ensure effective delivery.

Request Sample Copy of this Report @ https://www.maximizemarketresearch.com/request-sample/259289/

Nucleic Acid Therapeutics Market Segmentation

By Types

• Antisense oligonucleotides (ASOs)
• RNA interference (RNAi)
• Small interfering RNA (siRNA)
• Others

By Application

• Monogenetic disorders
• Multi-genetic disorders

By End User

• Hospitals and Clinics
• Academic and Research Institutes
• Others

Nucleic Acid Therapeutics Market's Key Players Include

• Novartis Pharma AG
• Ionis Pharmaceuticals, Inc.
• Arbutus Biopharma
• Thermo Fisher Scientific
• Agilent
• Alynylam Pharmaceuticals
• Nippon Shinyaku
• Silence Therapeutics plc
• Pfizer
• Sarepta Therapeutics
• Roche Holding AG
• Eli Lilly and Company
• Copernicus Therapeutics Inc.
• Sumitomo Chemical Co., Ltd.
• Aldevron
• Genzyme Sanofi
• lonis Pharmaceuticals, Inc.
• Moderna

𝐅𝐨𝐫 𝐚 𝐝𝐞𝐞𝐩𝐞𝐫 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤: https://www.maximizemarketresearch.com/market-report/nucleic-acid-therapeutics-market/259289/

Key questions answered in the Nucleic Acid Therapeutics Market are:

• What is the demand pattern for the Nucleic Acid Therapeutics market?
• Which segment dominated the Nucleic Acid Therapeutics market growth?
• Who is the largest key player in the Nucleic Acid Therapeutics Market Growth?
• Which region held the largest share of the Nucleic Acid Therapeutics market?
• Who are the key players in the Nucleic Acid Therapeutics market?
• What is the growth rate of the Nucleic Acid Therapeutics Market?
• What are the factors expected to drive the Nucleic Acid Therapeutics market growth?
• What is the Nucleic Acid Therapeutics Market?
• What was the Nucleic Acid Therapeutics market size in 2023?
• What is the expected Nucleic Acid Therapeutics market size by 2030?

Key Offerings:

• Past Market Size and Competitive Landscape (2018 to 2022)
• Past Pricing and price curve by region (2018 to 2022)
• Market Size, Share, Size & Forecast by Different Segment | 2024-2030
• Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by Region
• Market Segmentation - A detailed analysis by Type, Application, End-User, and Region.
• Competitive Landscape - Profiles of selected key players by region from a strategic perspective
 Competitive landscape - Market Leaders, Market Followers, Regional player
 Competitive benchmarking of key players by region
• PESTLE Analysis
• PORTER's analysis
• Value chain and supply chain analysis

Maximize Market Research is leading Healthcare Research Firm, has also published the following reports:

The Phytoestrogen Supplements Market size was valued at USD 3.21 Billion in 2023 and the total Phytoestrogen Supplements Market size is expected to grow at a CAGR of 5.66% from 2024 to 2030, reaching nearly USD 4.72 Billion by 2030.

Phytoestrogen Supplements Market : https://www.maximizemarketresearch.com/market-report/phytoestrogen-supplements-market/259141/

The Hyperuricemia Drugs Market size was valued at USD 5.08 Billion in 2023 and the total Hyperuricemia Drugs Market revenue is expected to grow at a CAGR of 8.52% from 2024 to 2030, reaching nearly USD 9.00 Billion by 2030.

Hyperuricemia Drugs Market : https://www.maximizemarketresearch.com/market-report/hyperuricemia-drugs-market/234607/

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical categories and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, category and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nucleic Acid Therapeutics Market is to Hit USD 12.09 billion in 2030 at a growth rate of 12.71% as per Maximize Market Research study here

News-ID: 3641678 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD

Brominated Flame Retardants Market to Grow from $13.75 Billion in 2023 to $17.85 Billion by 2030, at a 3.8% CAGR
Brominated Flame Retardants Market to Grow from $13.75 Billion in 2023 to $17.85 …
𝐁𝐫𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐅𝐥𝐚𝐦𝐞 𝐑𝐞𝐭𝐚𝐫𝐝𝐚𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 : The Brominated Flame Retardants Market is experiencing changes in growth driven by evolving regulations and increasing awareness of environmental and health concerns. Demand for brominated flame retardants, which are chemicals added to materials to prevent or slow down the spread of fire, is influenced by their use in various applications such as electronics, automotive parts, and building
Pre-Engineered Buildings Market to Reach USD 22456.37 Mn by 2030, Growing at 11.5% CAGR
Pre-Engineered Buildings Market to Reach USD 22456.37 Mn by 2030, Growing at 11. …
𝐏𝐫𝐞-𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐞𝐝 𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 : The Pre-Engineered Buildings (PEB) market has experienced a notable increase in growth and demand. This surge is driven by several factors, including the rising need for quick construction solutions, cost-effectiveness, and the adaptability of pre-engineered buildings for various applications such as commercial, industrial, and residential use. These buildings offer advantages like reduced construction time, lower labor costs, and
Wire Bonder Equipment Market: US$ 801.03 Mn in 2022, Projected to Reach US$ 1534.36 Mn by 2029, Growing at a CAGR of 9.73%
Wire Bonder Equipment Market: US$ 801.03 Mn in 2022, Projected to Reach US$ 1534 …
𝐖𝐢𝐫𝐞 𝐁𝐨𝐧𝐝𝐞𝐫 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 : The Wire Bonder Equipment market is experiencing a significant increase in demand, driven by the growing need for advanced semiconductor devices and miniaturized electronic components. As technology continues to evolve, the demand for high-performance and reliable wire bonding equipment is on the rise, particularly in sectors such as consumer electronics, automotive, and telecommunications. This demand surge is
Automotive Shock Absorber Market to Reach USD 18.47 Bn by 2030 at 7.2% CAGR
Automotive Shock Absorber Market to Reach USD 18.47 Bn by 2030 at 7.2% CAGR
𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐒𝐡𝐨𝐜𝐤 𝐀𝐛𝐬𝐨𝐫𝐛𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐨𝐫 𝐃𝐞𝐦𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐨𝐫 𝐃𝐞𝐜𝐫𝐞𝐚𝐬𝐞 𝐟𝐨𝐫 𝐰𝐡𝐚𝐭 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐬 : The Automotive Shock Absorber Market is witnessing steady growth, driven by the increasing demand for enhanced vehicle comfort and safety. As consumer preferences shift towards smoother and more stable rides, the need for advanced shock absorbers in both passenger and commercial vehicles is rising. The market is also benefiting from the expansion of the automotive industry in

All 5 Releases


More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from